BenevolentAI
ben phase study recruitment completed phase clinical study design day wash out from any existing medication day placebo run in day bid dosing on affected skin a maximum of placebo active moderate mild patient ratio total of patients active placebo day final safety assessment current status achieved end patients moderate and mild completed march anticipated end march our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and if approved | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
18 of 38
Related slides by other companies
Ocuphire Pharma
Investor Day
January 2022
zeta phase design placebo bid | Ocuphire Pharma
Equillium
Investor Presentation
February 2024
phase study of in adults with moderate to severe potential target product profile alternative to with at least comparable efficacy patient administered weekly weekly subcutaneous injection similar to | Equillium
Adagio Therapeutics
Results
June 2022
results from the phase randomized double blind placebo controlled trial to evaluate the efficacy and safety of in the treatment of ambulatory participants with mild or moderate covid stamp microbe | Adagio Therapeutics
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io